美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
75834-268-05	75834-268	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20210215	N/A	ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	10 mg/1	500 TABLET in 1 BOTTLE (75834-268-05)
24689-921-01	24689-921	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20240617	N/A	ANDA	ANDA209696	APNAR PHARMA LP	BUSPIRONE HYDROCHLORIDE	15 mg/1	100 TABLET in 1 BOTTLE (24689-921-01)
24689-921-05	24689-921	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20240617	N/A	ANDA	ANDA209696	APNAR PHARMA LP	BUSPIRONE HYDROCHLORIDE	15 mg/1	500 TABLET in 1 BOTTLE (24689-921-05)
24689-921-06	24689-921	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20240617	N/A	ANDA	ANDA209696	APNAR PHARMA LP	BUSPIRONE HYDROCHLORIDE	15 mg/1	60 TABLET in 1 BOTTLE (24689-921-06)
75834-266-01	75834-266	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20210215	N/A	ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5 mg/1	100 TABLET in 1 BOTTLE (75834-266-01)
75834-266-05	75834-266	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20210215	N/A	ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	5 mg/1	500 TABLET in 1 BOTTLE (75834-266-05)
75834-270-60	75834-270	HUMAN PRESCRIPTION DRUG	Buspirone Hydrochloride	Buspirone Hydrochloride	TABLET	ORAL	20210215	N/A	ANDA	ANDA209696	Nivagen Pharmaceuticals Inc.	BUSPIRONE HYDROCHLORIDE	30 mg/1	60 TABLET in 1 BOTTLE (75834-270-60)
71610-291-60	71610-291	HUMAN PRESCRIPTION DRUG	BusPIRone Hydrochloride	BusPIRone Hydrochloride	TABLET	ORAL	20190605	N/A	ANDA	ANDA209696	Aphena Pharma Solutions - Tennessee, LLC	BUSPIRONE HYDROCHLORIDE	15 mg/1	90 TABLET in 1 BOTTLE (71610-291-60)